Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 123
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Clin Exp Allergy ; 42(1): 66-75, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22092594

RESUMEN

BACKGROUND: Atopic dermatitis (AD) and respiratory syncytial virus lower respiratory tract infection (RSV LRTI) are common diseases during early life. Impaired Th1-cell polarizing Toll-like receptor (TLR) responses play an important role in the pathogenesis of both diseases. Neonatal TLR-mediated production of Th1-type cytokines is decreased at birth, but rapidly increases during the first month of life. OBJECTIVE: To determine whether decreased TLR-mediated production of Th1-polarizing cytokines, at the age of 1 month is associated with subsequent AD or RSV LRTI. METHODS: A prospective healthy birth cohort study was performed. Whole blood concentrations of innate immune cells and TLR-mediated cytokine responses were measured at the age of 1 month in 291 neonates. AD was determined by a physician questionnaire at the age of 1 year and RSV LRTI was defined as parent-reported respiratory symptoms and presence of RSV RNA in a nose-throat specimen. RESULTS: Of participating neonates, 45 (15%) developed AD and 41 (14%) developed RSV LRTI. Risks of AD and RSV LRTI were not associated (χ(2) , P = 1.00). AD was associated with decreased concentrations of basophils (7.6 vs. 14.0 × 10(6) /mL, P = 0.002) and plasmacytoid dendritic cells (17.0 vs. 20.5 × 10(6) /mL, P = 0.04), increased concentrations of NK-cells (79.7 vs. 45.1 × 10(6) /mL, P = 0.03), and twofold lower TLR4-mediated IL-10 production (P = 0.001). In contrast, RSV LRTI was associated neither with neonatal concentrations of innate immune cells, nor with TLR-mediated TNF-α, IL-12p70, IL-10 or IFN-α production. CONCLUSIONS AND CLINICAL RELEVANCE: Atopic dermatitis, but not RSV LRTI, is associated with distinct pre-symptomatic differences in the innate immune system. We hypothesize that decreased neonatal IL-10-mediated immune regulation during early life might play a causal role in the initiation of AD.


Asunto(s)
Dermatitis Atópica/inmunología , Dermatitis Atópica/fisiopatología , Regulación hacia Abajo , Interleucina-10/metabolismo , Receptor Toll-Like 4/inmunología , Bronquiolitis Viral/inmunología , Bronquiolitis Viral/fisiopatología , Bronquiolitis Viral/virología , Citocinas/biosíntesis , Femenino , Humanos , Inmunidad Innata , Lactante , Masculino , Infecciones por Virus Sincitial Respiratorio/inmunología , Infecciones por Virus Sincitial Respiratorio/fisiopatología , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitial Respiratorio Humano/inmunología , Células TH1/inmunología , Receptor Toll-Like 4/metabolismo
2.
Pediatr Allergy Immunol ; 23(1): 65-74, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22103307

RESUMEN

BACKGROUND: Neonatal Toll-like receptor (TLR) responses are biased toward Th2-polarizing responses at birth and rapidly mature toward more balanced responses during the first month of life. Postnatal TLR maturation may be guided by environmental exposure. AIMS: To determine the environmental determinants of neonatal TLR function. MATERIALS AND METHODS: A prospective birth cohort study was performed in 291 healthy term neonates. Mode of delivery, breastfeeding, birth month, siblings, pets and parental smoking were analyzed in relation to neonatal innate immune parameters at the age of 1 month. Whole blood concentrations of innate immune cells were measured by flow cytometry. In vitro TLR-mediated cytokine production was determined by ELISA. RESULTS: Breastfeeding was the major determinant of neonatal innate immunity, associated with 5 (31%) of neonatal innate immune parameters, of which the association with TLR7-mediated IL-10 production was most significant (76 pg/ml in breastfed neonates vs. 293 pg/ml in formula-fed neonates, p = 0.001). Of innate immune variables, TLR3-mediated IL-12p70 production was highly associated with environmental exposures (pets, breastfeeding and mode of delivery), whereas TLR9-mediated cytokine responses were not associated with any environmental factor. CONCLUSION: Neonatal innate immune responses are differentially modulated by environmental exposure in the first month of life. The protective effect of breastfeeding against subsequent infections and atopy might be explained by its innate immune modulatory effects in the first month of life.


Asunto(s)
Lactancia Materna , Citocinas/sangre , Hipersensibilidad/inmunología , Sistema Inmunológico/crecimiento & desarrollo , Inmunidad Innata/inmunología , Receptores Toll-Like/inmunología , Contaminación del Aire Interior/efectos adversos , Alérgenos/efectos adversos , Estudios de Cohortes , Citocinas/inmunología , Femenino , Humanos , Hipótesis de la Higiene , Hipersensibilidad/epidemiología , Sistema Inmunológico/inmunología , Recién Nacido , Interleucina-10/sangre , Interleucina-10/inmunología , Interleucina-12/sangre , Interleucina-12/inmunología , Recuento de Leucocitos , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Masculino , Estudios Prospectivos , Contaminación por Humo de Tabaco/efectos adversos , Receptor Toll-Like 3/inmunología , Receptor Toll-Like 7/inmunología , Receptor Toll-Like 9/inmunología
3.
Eur Respir J ; 38(3): 664-71, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21233268

RESUMEN

This study investigated the relationship between parental lung function and their children's lung function measured early in life. Infants were participants in the Wheezing Illnesses Study Leidsche Rijn (WHISTLER). Lung function was measured before the age of 2 months using the single occlusion technique. Parental data on lung function (spirometry), medical history and environmental factors were obtained from the linked database of the Utrecht Health Project. Parental data on pulmonary function and covariates were available in 546 infants. Univariate linear regression analysis demonstrated a significant positive relationship between the infant's respiratory compliance and parental forced expiratory flow at 25-75% of forced vital capacity (FEF(25-75%))(,) forced expiratory volume in 1 s (FEV(1)) and forced vital capacity. A significant negative relationship was found between the infant's respiratory resistance and parental FEF(25-75%)and FEV(1). No significant relationship was found between the infant's respiratory time constant and parental lung function. Adjusting for body size partially reduced the significance of the observed relationship; adjusting for shared environmental factors did not change the observed results. Parental lung function levels are predictors of the respiratory mechanics of their newborn infants, which can only partially be explained by familial aggregation of body size. This suggests genetic mechanisms in familial aggregation of lung function, which are already detectable early in life.


Asunto(s)
Enfermedades Pulmonares/diagnóstico , Pulmón/fisiología , Adulto , Preescolar , Estudios de Cohortes , Femenino , Volumen Espiratorio Forzado , Humanos , Lactante , Recién Nacido , Masculino , Padres , Análisis de Regresión , Pruebas de Función Respiratoria/métodos , Mecánica Respiratoria , Factores de Riesgo , Capacidad Vital
4.
J Med Virol ; 82(7): 1266-71, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20513094

RESUMEN

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, with remarkable variability in disease severity. Factors determining severity of disease in previously healthy infants are still unclear. It was hypothesized that disease severity is correlated with viral load in primary RSV infection. Infants of a healthy birth cohort were included at signs of their first respiratory tract infection. Nasopharyngeal aspirate was obtained within 48-96 hr and disease severity was assessed with a previously published severity scoring model. PCR was applied to test the aspirates in a semi-quantitative way for the presence of 10 respiratory pathogens. In case of multiple infection, the pathogen with the highest load was defined as the primary pathogen. The correlation between disease severity and viral load was analyzed. A total of 82 infants were included over a period of 2 years. Median age at first respiratory tract infection was 3 months. Pathogens were detected in 77 (94%) infants; more than one pathogen was detected in 35 (43%) infants. RSV was present in aspirates of 30 infants; in 16 aspirates RSV was the primary pathogen. A negative correlation between RSV CT-value and disease severity was found in all RSV cases (rho = -0.52, P = 0.003) and in cases with RSV as the primary pathogen (rho = -0.54, P = 0.03). In conclusion, this is the first report on viral loads in previously healthy infants with RSV infection in the community. Disease severity correlated positively with viral load during primary RSV infection.


Asunto(s)
Infecciones por Virus Sincitial Respiratorio/patología , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitiales Respiratorios/aislamiento & purificación , Femenino , Humanos , Lactante , Masculino , Nasofaringe/virología , Reacción en Cadena de la Polimerasa , Virus Sincitiales Respiratorios/genética , Índice de Severidad de la Enfermedad , Carga Viral
5.
Eur J Clin Microbiol Infect Dis ; 29(4): 365-71, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20111881

RESUMEN

In this study, we present the multiple detection of respiratory viruses in infants during primary respiratory illness, investigate the sensitivity of nasal swabs and nasopharyngeal aspirates, and assess whether patient characteristics and viral load played a role in the sensitivity. Healthy infants were included at signs of first respiratory tract infection. Paired nasopharyngeal aspirates and nasal swabs were collected. Real-time polymerase chain reaction (PCR) was carried out for 11 respiratory pathogens. Paired nasopharyngeal aspirates and nasal swabs were collected in 98 infants. Rhinovirus (n = 67) and respiratory syncytial virus (n = 39) were the most frequently detected. Co-infection occurred in 48% (n = 45) of the infants. The sensitivity of the nasal swab was lower than the nasopharyngeal aspirate, in particular, for respiratory syncytial virus (51% vs. 100%) and rhinovirus (75% vs. 97%). The sensitivity of the nasal swab was strongly determined by the cycle threshold (CT) value (p < 0.001). The sensitivity of the swab for respiratory syncytial virus, but not rhinovirus, was 100% in children with severe symptoms (score >or=11). It is concluded that, for community-based studies and surveillance purposes, the nasal swab can be used, though the sensitivity is lower than the aspirate, in particular, for the detection of mild cases of respiratory syncytial virus (RSV) infection.


Asunto(s)
Nasofaringe/virología , Nariz/virología , Reacción en Cadena de la Polimerasa/métodos , Infecciones del Sistema Respiratorio/virología , Virosis/diagnóstico , Virus/clasificación , Virus/aislamiento & purificación , Comorbilidad , Femenino , Humanos , Lactante , Masculino , Infecciones del Sistema Respiratorio/epidemiología , Sensibilidad y Especificidad , Carga Viral , Virosis/epidemiología , Virosis/virología
6.
Clin Immunol ; 133(2): 228-37, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19648060

RESUMEN

Newborns are highly susceptible to infectious diseases, which may be due to impaired immune responses. This study aims to characterize the ontogeny of neonatal TLR-based innate immunity during the first month of life. Cellularity and Toll-like receptor (TLR) agonist-induced cytokine production were compared between cord blood obtained from healthy neonates born after uncomplicated gestation and delivery (n=18), neonatal venous blood obtained at the age of one month (n=96), and adult venous blood (n=17). Cord blood TLR agonist-induced production of the Th1-polarizing cytokines IL-12p70 and IFN-alpha was generally impaired, but for TLR3, 7 and 9 agonists, rapidly increased to adult levels during the first month of life. In contrast, TLR4 demonstrated a slower maturation, with low LPS-induced IL-12p70 production and high IL-10 production up until the age of one month. Polarization in neonatal cytokine responses to LPS could contribute to neonatal susceptibility to severe bacterial infection.


Asunto(s)
Sangre/metabolismo , Citocinas/sangre , Sistema Inmunológico/crecimiento & desarrollo , Interleucina-10/sangre , Interleucina-12/sangre , Lipopolisacáridos/farmacología , Receptor Toll-Like 4/agonistas , Adulto , Sangre/efectos de los fármacos , Sangre/inmunología , Femenino , Sangre Fetal/citología , Sangre Fetal/efectos de los fármacos , Sangre Fetal/inmunología , Sangre Fetal/metabolismo , Expresión Génica/efectos de los fármacos , Expresión Génica/inmunología , Humanos , Sistema Inmunológico/inmunología , Inmunidad Innata/inmunología , Recién Nacido , Interferón-alfa/sangre , Interferón gamma/farmacología , Interleucina-10/genética , Interleucina-10/metabolismo , Interleucina-12/metabolismo , Subunidad p35 de la Interleucina-12/genética , Subunidad p40 de la Interleucina-12/genética , Interleucina-6/genética , Recuento de Leucocitos , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Masculino , Plasma/inmunología , Receptores Toll-Like/agonistas , Factor de Necrosis Tumoral alfa/genética
7.
Eur Respir J ; 34(3): 531-51, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19720806

RESUMEN

Detailed literature searches were carried out in seven respiratory disease areas. Therapeutic evidence for efficacy of medicinal products was assessed using the Grades of Recommendation, Assessment and Evaluation (GRADE) methodology, as well as an assessment of safety and side-effects. Systemic corticosteroids may reduce the development of bronchopulmonary dysplasia but have serious side-effects. Antioxidants need further study to demonstrate whether they have long-term benefits. Treatments for acute bronchiolitis have shown little benefit but new antiviral and monoclonal antibodies need further assessment. Well-constructed studies are needed to confirm the value of inhaled corticosteroids and/or montelukast in the management of viral-induced wheeze. Corticosteroids are the treatment of choice in croup. Minimal or no information is available for the treatment of congenital lung abnormalities, bronchiolitis obliterans and interstitial lung disease.


Asunto(s)
Antiinflamatorios/uso terapéutico , Enfermedades Pulmonares/tratamiento farmacológico , Fármacos del Sistema Respiratorio/uso terapéutico , Factores de Edad , Antibacterianos/uso terapéutico , Antioxidantes/uso terapéutico , Niño , Preescolar , Humanos , Lactante , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro , Enfermedades Pulmonares/etiología , Enfermedades Pulmonares/patología
8.
Allergy ; 64(9): 1349-58, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19392993

RESUMEN

BACKGROUND: Modification of the intestinal microbiota by administration of probiotic bacteria may be a potential approach to prevent allergic disease. We aimed to study primary prevention of allergic disease in high-risk children by pre- and postnatal supplementation of selected probiotic bacteria. METHODS: In a double-blind, randomized, placebo-controlled trial, a mixture of probiotic bacteria selected by in-vitro experiments (Bifidobacterium bifidum, Bifidobacterium lactis, and Lactococcus lactis; Ecologic Panda) was prenatally administered to mothers of high-risk children (i.e. positive family history of allergic disease) and to their offspring for the first 12 months of life. RESULTS: Parental-reported eczema during the first 3 months of life was significantly lower in the intervention group compared with placebo, 6/50 vs 15/52 (P = 0.035). After 3 months, the incidence of eczema was similar in both groups. Cumulative incidence of parental-reported eczema at 1 and 2 years was 23/50 (intervention) vs 31/48 (placebo) and 27 (intervention) vs 34 (placebo), respectively. The number needed to treat was 5.9 at age 3 and 12 months and 6.7 at age 2 years. The intervention group was significantly more frequently colonized with higher numbers of Lc. lactis. Furthermore, at age 3 months, in vitro production of IL-5 (146 pg/ml vs 72 pg/ml; P = 0.04) was decreased in the probiotic-group compared with the placebo-group. CONCLUSIONS: This particular combination of probiotic bacteria shows a preventive effect on the incidence of eczema in high-risk children, which seems to be sustained during the first 2 years of life. In addition to previous studies, the preventive effect appears to be established within the first 3 months of life.


Asunto(s)
Bifidobacterium , Eccema/prevención & control , Hipersensibilidad/prevención & control , Lactococcus lactis , Probióticos/uso terapéutico , Adulto , Citocinas/sangre , Método Doble Ciego , Eccema/inmunología , Eccema/microbiología , Femenino , Humanos , Hipersensibilidad/inmunología , Hipersensibilidad/microbiología , Inmunoglobulina E/sangre , Lactante , Masculino , Embarazo
9.
Eur Respir J ; 32(5): 1203-12, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18614563

RESUMEN

Although a marked increase in the reporting of wheezing symptoms since the mid-1970s has been described, the underlying immunopathology of the different wheezing phenotypes has not been clarified. Since differences in gene expression might be involved, the objective of the present study was to identify gene expression profiles in CD4+ T-cells from two distinct infant wheezing phenotypes. The gene expression profiles of peripheral CD4+ T-cells were compared by means of microarray analysis of six transient wheezers, six persistent wheezers and seven healthy controls. The differentially expressed genes were subsequently validated by RT-PCR. The differential gene expression profiles reflected common immunological pathways involved in apoptosis or proliferation of T-cells. Furthermore, both wheezing phenotypes showed decreased expression of the complement component 5 receptor 1 gene, a gene involved in the regulation of bronchial responsiveness. Moreover, differences in gene expression profiles were found in genes involved in the immune response against respiratory syncytial virus, such as those encoding signal transducer and activator of transcription 1 and an inflammatory mediator showing enhanced production in asthma (prostaglandin E(2) receptor 2). The present findings suggest that clinical symptoms of wheeze are reflected in common immunological pathways, whereas differences between wheezing phenotypes are, in part, reflected in distinct gene expression profiles.


Asunto(s)
Linfocitos T CD4-Positivos/metabolismo , Perfilación de la Expresión Génica , Ruidos Respiratorios/genética , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Recién Nacido , Masculino , Modelos Biológicos , Análisis de Secuencia por Matrices de Oligonucleótidos , Fenotipo , Receptores de Prostaglandina E/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
10.
J Asthma ; 45(9): 807-13, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18972300

RESUMEN

Asthma can have a negative effect on psychological and social well-being in childhood. Sports participation, school attendance, and quality of life are important issues for children with asthma and their parents. However, a structural evaluation of these factors is not always incorporated in the routine medical approach of children with asthma. Moreover, goals in asthma treatment, such as minimal symptoms and normal activity levels, are achieved in a minority of children. This review describes determinants that are important for the well-being of children with asthma and their parents. Besides the control of symptoms, factors such as sports participation, socializing in peer groups, school attendance, and quality of life must be considered. These issues are relevant when evaluating the management of children and adolescents with asthma. A multidisciplinary evaluation by a pediatrician, school nurse, gym teacher, and psychologist might contribute to an important decrease in the impact of asthma on daily life.


Asunto(s)
Absentismo , Asma/psicología , Relaciones Interpersonales , Calidad de Vida , Deportes , Antiasmáticos/uso terapéutico , Asma/tratamiento farmacológico , Ambiente , Estado de Salud , Humanos , Autoeficacia
11.
Ned Tijdschr Geneeskd ; 151(16): 932, 2007 Apr 21.
Artículo en Holandés | MEDLINE | ID: mdl-17500347

RESUMEN

The contemporary physician is not merely a professional who is trained in the recognition of clinical syndromes and the application of evidence-based medicine. A good understanding of the basic biomedical sciences is necessary to comprehend what is wrong with a patient and what form of treatment is the most appropriate, especially if a disease manifests itself in an unfamiliar way.


Asunto(s)
Curriculum , Educación Médica/normas , Ciencia/educación , Medicina Basada en la Evidencia , Humanos , Aprendizaje Basado en Problemas
12.
J Neuroimmunol ; 160(1-2): 170-7, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15710470

RESUMEN

To determine the contribution of vascular endothelial growth factor (VEGF) to cerebral edema formation in bacterial meningitis, we used a VEGF neutralizing antibody to block VEGF in rabbits, following induction of meningitis by intracisternal inoculation with 10(9) heat-killed pneumococci. At 8 h, cerebrospinal fluid (CSF) VEGF was significantly elevated in infected untreated animals, and correlated with CSF white blood cell (WBC) count (r=0.56, P=0.004), and brain water content (r=0.42, P=0.04). Blocking of VEGF did not attenuate brain edema, blood-brain barrier disruption, or CSF pleocytosis. The functional role of VEGF in the pathophysiology of BM remains elusive.


Asunto(s)
Anticuerpos Bloqueadores/administración & dosificación , Edema Encefálico/inmunología , Edema Encefálico/fisiopatología , Permeabilidad Capilar/inmunología , Meningitis Neumocócica/inmunología , Meningitis Neumocócica/fisiopatología , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Factor A de Crecimiento Endotelial Vascular/inmunología , Animales , Anticuerpos Bloqueadores/farmacología , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/farmacología , Anticuerpos Monoclonales Humanizados , Bevacizumab , Edema Encefálico/sangre , Edema Encefálico/líquido cefalorraquídeo , Movimiento Celular/inmunología , Cisterna Magna , Femenino , Humanos , Inyecciones Intravenosas , Leucocitos/inmunología , Leucocitos/patología , Meningitis Neumocócica/sangre , Meningitis Neumocócica/líquido cefalorraquídeo , Ratones , Conejos , Factor A de Crecimiento Endotelial Vascular/sangre , Factor A de Crecimiento Endotelial Vascular/líquido cefalorraquídeo , Equilibrio Hidroelectrolítico
13.
J Clin Epidemiol ; 58(5): 495-502, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15845336

RESUMEN

BACKGROUND AND OBJECTIVES: Quality of life measurements can help to estimate the well-being of chronically ill patients, and disclose discrepancies in perception between physicians and patients that might otherwise interfere with the effectiveness of treatment. The objective was to investigate the differences in perception of quality of life between parents of chronically ill children and pediatricians. METHODS: A cross-sectional study was conducted in four tertiary pediatric care centers in The Netherlands. The Health Utilities Index mark 3 (HUI3) was used by 37 pediatricians and 279 parents of patients (children aged 1 to 17 years) with cystic fibrosis admitted either in daycare or for a pneumonia, or patients with newly diagnosed acute lymphoblastic leukemia, juvenile idiopathic arthritis, or asthma. RESULTS: Differences in perception of quality of life between parents and pediatricians appeared to be dependent of the disease. In patients with acute lymphoblastic leukemia (OR 7.4; [95% CI 2.88-18.97], juvenile idiopathic arthritis (4.7; [95% CI 2.00-11.22]), and asthma (2.3; [95% CI 1.13-4.69]) a difference in perception was more likely to occur than in patients with cystic fibrosis admitted in daycare. CONCLUSION: At the onset of a chronic disease, the parents of pediatric patients may be misunderstood by health care professionals, especially in subjective attributes. Assessment of quality of life may contribute to better understanding between pediatricians and parents, and thus may even enhance compliance and treatment effects.


Asunto(s)
Enfermedad Crónica/rehabilitación , Padres/psicología , Pediatría , Calidad de Vida , Percepción Social , Adolescente , Artritis Juvenil/fisiopatología , Artritis Juvenil/psicología , Artritis Juvenil/rehabilitación , Asma/fisiopatología , Asma/psicología , Asma/rehabilitación , Niño , Preescolar , Enfermedad Crónica/psicología , Cognición , Estudios Transversales , Fibrosis Quística/fisiopatología , Fibrosis Quística/psicología , Fibrosis Quística/rehabilitación , Emociones , Femenino , Indicadores de Salud , Humanos , Lactante , Locomoción/fisiología , Masculino , Dolor/fisiopatología , Leucemia-Linfoma Linfoblástico de Células Precursoras/fisiopatología , Leucemia-Linfoma Linfoblástico de Células Precursoras/psicología , Leucemia-Linfoma Linfoblástico de Células Precursoras/rehabilitación , Habla/fisiología
14.
J Clin Epidemiol ; 57(7): 653-61, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15358393

RESUMEN

OBJECTIVE: In addition to traditional clinical markers, quality-of-life assessment can be helpful to estimate the well-being of patients. Discrepancies in perception of well-being between physicians and patients may interfere with the effectiveness of treatment. A systematic review and meta-analysis were performed to explore the (dis-)agreement in quality-of-life assessments between patients and physicians. STUDY DESIGN AND SETTING: Data on the proportion agreement of paired observations were collected from Medline, Embase, Psychlit, and Social Abstracts. RESULTS: Of the 1,316 articles found, six met the selection criteria, four studied the proportion agreement between children and physicians, and all six the proportion agreement between parents and physicians. None examined the magnitude of over- or underestimation by physicians. The agreement was lower in the more subjective domains (0.54-0.77) in comparison to the more objective domains (0.79-0.94). CONCLUSION: Quality-of-life assessment should be integrated in clinical practice. During long-term treatment the perception of the patients' well-being by physicians and patients themselves can easily diverge from each other, resulting in misunderstandings about the treatment and its usefulness in relation to perceived quality of life, and may even become the base for noncompliance.


Asunto(s)
Actitud del Personal de Salud , Actitud Frente a la Salud , Indicadores de Salud , Calidad de Vida , Humanos , Médicos/psicología , Reproducibilidad de los Resultados
15.
Chest ; 105(1): 301-2, 1994 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8275758

RESUMEN

A neonate with respiratory distress due to a right pneumothorax is presented. After drainage of the pneumothorax, atelectasis of the entire right lung developed. Because the atelectasis persisted, bronchoscopy was performed. On bronchoscopy the carina and right main-stem bronchus could not be visualized. Thoracotomy showed that the right main-stem bronchus was obstructed by a space-occupying lesion that was originating from the right upper lobe. Therefore, a sleeve resection of the right upper lobe was performed, and the right main-stem bronchus was reconstructed. Microscopic examination of the resected right upper lobe showed multiple chondromata. The lesions were located both in the lung parenchyma immediately beneath the pleura and in the bronchial wall. Pulmonary chondromata are rarely diagnosed in children. To our knowledge, this is the youngest patient ever presented with pulmonary chondromata.


Asunto(s)
Condroma/complicaciones , Neoplasias Pulmonares/complicaciones , Insuficiencia Respiratoria/etiología , Humanos , Lactante , Recién Nacido , Masculino , Neoplasias Pleurales/complicaciones , Neumotórax/etiología , Atelectasia Pulmonar/etiología
16.
Pediatr Infect Dis J ; 16(5): 479-81, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9154540

RESUMEN

BACKGROUND: Among the lower respiratory tract infections during infancy requiring hospitalization, respiratory syncytial virus (RSV) bronchiolitis is the most frequent disease entity. Nevertheless treatment remains controversial. METHODS: A poll among the European Society for Paediatric Infectious Diseases (ESPID) members was conducted to determine the respective local and national treatment policies of RSV bronchiolitis. RESULTS: The questionnaire was returned by 88 centers represented in ESPID (response rate 64%). Ribavirin was used occasionally for high risk patients in 34 centers although 16 hospitals follow the guidelines of the Red Book Committee of the American Academy of Pediatrics. There were no centers using ribavirin for all patients. Bronchodilator treatment was used universally in various combinations for all patients in 54 centers and for all high risk patients in 15. Corticosteroids were used by > 80% of ESPID colleagues in various combinations of administration routes. CONCLUSION: The lack of effective treatment for RSV bronchiolitis and the controversy in the literature concerning antiviral, bronchodilator and antiinflammatory therapy leads to inconsistent treatment strategies.


Asunto(s)
Bronquiolitis Viral/tratamiento farmacológico , Infecciones por Virus Sincitial Respiratorio/tratamiento farmacológico , Corticoesteroides/uso terapéutico , Adulto , Antivirales/uso terapéutico , Broncodilatadores/uso terapéutico , Enfermedades Transmisibles/tratamiento farmacológico , Humanos , Lactante , Formulación de Políticas , Vigilancia de la Población , Evaluación de Programas y Proyectos de Salud , Ribavirina/uso terapéutico , Encuestas y Cuestionarios
17.
Pediatr Infect Dis J ; 20(2): 160-3, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11224834

RESUMEN

OBJECTIVE: To calculate both medical consumption and socioeconomic effects related to hospitalization for respiratory syncytial virus (RSV) infection in the Netherlands. METHODS: During the winter seasons of 1998 to 2000, parents of all patients hospitalized for RSV in three secondary care hospitals were asked to fill out questionnaires focusing on the 2 weeks before hospitalization, the period in hospital and the 2 weeks after discharge. The questions concerned workdays lost, level of education and current profession, extra childcare needed, consultation by the family physician and drugs prescribed and costs of travelling. RESULTS: Seventy-three children were hospitalized. Median age was 79 days (range, 9 to 537 days), and median weight was 5,295 g (range, 3130 to 10,600 g). Three children were born preterm. Parents had 2 (range, 0 to 6) telephone contacts with the family doctor; the child was seen 2 (range, 0 to 4) times before hospitalization. Parents lost 0.5 workday before hospitalization. Duration of hospitalization was 5 days median (range, 1 to 12 days). Parents lost 1.5 (range, 0 to 9) workdays during hospitalization and drove 118 (range, 6 to 550) miles to visit their child. In the period after discharge expenses were negligible. Calculation of all parameters into currency resulted in a total amount of $2,200 per child hospitalized for RSV. Workdays lost, costs for travelling and consultation of family doctors resulted in $295 per child. CONCLUSIONS: RSV infections necessitating hospitalization in a secondary care hospital have remarkable effects on parental expenses, parental absence from work and medical consumption. On top of the hospital-related costs 15% should be added for parental expenses and socioeconomic costs.


Asunto(s)
Costo de Enfermedad , Hospitalización/economía , Cuidado del Lactante/economía , Infecciones por Virus Sincitial Respiratorio/economía , Absentismo , Femenino , Costos de Hospital , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Tiempo de Internación , Masculino , Países Bajos/epidemiología , Infecciones por Virus Sincitial Respiratorio/epidemiología , Estaciones del Año , Factores Socioeconómicos , Encuestas y Cuestionarios , Trabajo/economía
18.
Pediatr Infect Dis J ; 20(2): 171-7, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11224837

RESUMEN

BACKGROUND: Gram-negative bacteremia in children, a major cause of morbidity and mortality, may in part be induced by intensive treatment procedures and nonspecific use of antibiotics. Our primary objective was to study the causal relationship between the use of vancomycin and Gram-negative bacteremia, for which this antibiotic is not specifically indicated. METHODS: The study was conducted in a 105-bed tertiary care children's hospital in the period of 1994 to 1997. The study pertains to a cohort of children with suspected bacteremia, in whom a blood culture was performed during hospital stay. Using the bacteriologic laboratory registration system, we selected all pediatric cases with bacteriologically proved Gram-negative bacteremia (n = 105) and a random sample of 225 pediatric controls with negative blood cultures. Using logistic regression analysis we examined associations between Gram-negative bacteremia and the following factors: preceding use of antibiotics, antacids, corticosteroids, surgery, mechanical ventilation, parenteral nutrition, and invasive instrumentation; and the intensity of care assessed with the Therapeutic Intensity Scoring System (TISS 28). RESULTS: Gram-negative bacteremia was positively associated with the use of aminoglycosides, cephalosporins, surgical interventions, central venous catheters, parenteral nutrition, antacids and dexamethasone. The strongest association was with the use of vancomycin (odds ratio, 8.1; 95% confidence interval, 3.1 to 20.9). In a multiple logistic regression model containing all above-mentioned variables, the use of vancomycin remained positively and strongly associated with Gram-negative bacteremia (odds ratio, 3.88; 95% confidence interval, 1.34 to 11.21). Further adjustments and restrictions in the analysis did not materially change these findings concerning vancomycin. CONCLUSIONS: Among children suspected of bacteremia there are several drugs and clinical procedures influencing the risk for Gram-negative bacteremia. Empiric use of vancomycin is strongly and independently associated with Gram-negative bacteremia. The safety of using vancomycin solely on the basis of suspicion of bacteremia in children may not be warranted.


Asunto(s)
Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacterias Gramnegativas/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Vancomicina/uso terapéutico , Corticoesteroides/efectos adversos , Antiácidos/efectos adversos , Antibacterianos/farmacología , Bacteriemia/epidemiología , Estudios de Cohortes , Femenino , Cirugía General , Bacterias Gramnegativas/aislamiento & purificación , Infecciones por Bacterias Gramnegativas/epidemiología , Humanos , Lactante , Recién Nacido , Masculino , Oportunidad Relativa , Nutrición Parenteral/efectos adversos , Análisis de Regresión , Respiración Artificial , Factores de Riesgo , Vancomicina/farmacología , Resistencia a la Vancomicina
19.
Pediatr Infect Dis J ; 20(3): 277-82, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11303830

RESUMEN

BACKGROUND: Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is frequently followed by recurrent wheezing. Thus far no clinical risk factors have been identified to predict which infants will have wheezing episodes subsequent to RSV LRTI. OBJECTIVE: To determine clinical predictors for airway morbidity after RSV LRTI. METHODS: In a 1-year follow-up study we investigated the predictive value of auscultatory findings characteristic of airflow limitation (wheezing) during RSV LRTI for subsequent airway morbidity. Clinical characteristics, including the presence or absence of signs of airflow limitation, of hospitalized infants with RSV LRTI were prospectively recorded during 2 winter epidemics. During a 1-year follow-up period parents of 130 infants recorded daily airway symptoms. OUTCOME MEASURE: Recurrent wheezing defined as > or = 2 episodes of wheezing. RESULTS: Signs of airflow limitation during RSV LRTI were absent in 47 (36%) infants and present in 83 (64%) infants. Recurrent wheezing was recorded in 10 (21%) infants without signs of airflow limitation and in 51 (61%) with signs of airflow limitation during initial RSV LRTI (relative risk, 0.29, P < 0.001). In a multiple logistic regression model, airflow limitation during initial RSV LRTI proved independent from other clinical parameters, including age, parental history of asthma and smoke exposure. CONCLUSIONS: A sign of airflow limitation during RSV LRTI is the first useful clinical predictor for subsequent recurrent wheezing.


Asunto(s)
Ruidos Respiratorios/etiología , Infecciones por Virus Sincitial Respiratorio/complicaciones , Infecciones del Sistema Respiratorio/complicaciones , Auscultación , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino , Morbilidad , Recurrencia , Infecciones por Virus Sincitial Respiratorio/virología , Virus Sincitial Respiratorio Humano
20.
FEMS Immunol Med Microbiol ; 26(3-4): 189-95, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10575129

RESUMEN

Although bacterial superinfection in viral respiratory disease is a clinically well documented phenomenon, the pathogenic mechanisms are still poorly understood. Recent studies have revealed some of the mechanisms involved. Physical damage to respiratory cells as a result of viral infection may lead to opportunistic adherence of bacteria. Enhanced bacterial adherence by specific mechanisms has been documented for respiratory cells infected with influenza A virus, respiratory syncytial virus and adenovirus in both in vitro and in vivo models. To date, results of various experimental studies indicate that different mechanisms for increased bacterial adherence induced by viruses are operating for specific viral-bacterial combinations. In the present review, a number of key findings obtained during the past two decades is presented and discussed.


Asunto(s)
Infecciones Bacterianas/etiología , Infecciones del Sistema Respiratorio/complicaciones , Virosis/complicaciones , Animales , Infecciones Bacterianas/microbiología , Causalidad , Humanos , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/virología , Virosis/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA